Trial Profile
Comparison of the efficacy and safety of amisulpride versus low-dose amisulpride plus low-dose sulpiride in treatment of schizophrenia
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Amisulpride (Primary) ; Sulpiride (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 06 Jun 2012 New source identified and integrated: ClinicalTrials.gov record NCT01615185.
- 07 Sep 2011 Results presented at the 24th Annual Congress of the European College of Neuropsychopharmacology.
- 07 Sep 2011 New trial record